On 28 September 1928, Alexander Fleming returned to his laboratory at St Mary’s Hospital in London and examined a culture dish that had been contaminated by mould. Around the mould, the bacteria he had been studying did not grow. Fleming recognized that the clear area was more than a laboratory curiosity: it suggested that the mould released something capable of stopping bacterial growth. He called the substance penicillin, after the Penicillium mould. The discovery began with careful observation of an unexpected result, followed by experiments to understand what had happened.
The story is often told as a lucky accident, and chance did play a part: mould had entered a culture that was meant to contain bacteria. But noticing the effect required knowledge and attention. Fleming worked as a bacteriologist and was already interested in substances that could act against microbes. Instead of discarding the spoiled dish, he compared the area near the mould with the places where bacteria continued to grow. That difference gave him a question he could investigate: could the mould produce an antibacterial substance, and would its effect extend beyond this one plate?
Fleming and his colleagues tested the mould culture against several kinds of bacteria. The results suggested that the substance could inhibit important disease-causing microbes. Naming it penicillin gave researchers a way to discuss and study the finding, but it did not yet make a usable medicine. The active material was difficult to isolate and unstable, and the amount produced in the laboratory was small. Fleming published his observations, yet the practical possibilities were not immediately pursued on a large scale.
More than a decade later, researchers at Oxford University, including Howard Florey and Ernst Chain, returned to the problem. With a wider team, they worked on extracting, testing and producing penicillin in quantities that could be used to treat patients. Their work turned a laboratory observation into a treatment. During the 1940s, improved production made the antibiotic available to more people and helped doctors treat infections that had once been extremely dangerous. Fleming, Florey and Chain shared the 1945 Nobel Prize in Physiology or Medicine for their contributions.
This longer timeline matters. A discovery can open a door without completing the journey through it. Fleming identified a promising natural effect; other scientists developed methods to purify and manufacture the substance; clinicians studied how to use it. Technicians, nurses, manufacturers and public health teams also contributed to its use. The history of penicillin is therefore not a tale of one person solving every problem at once, but an example of scientific knowledge growing through exchange and persistence.
Penicillin changed medicine by giving doctors a powerful way to treat many bacterial infections. It made surgery and the care of wounds safer and saved countless lives. Antibiotics, however, do not work against viruses, and using them when they are not needed can contribute to antibiotic resistance. Bacteria can adapt, so these medicines must be used responsibly and according to medical advice.
The laboratory dish of 1928 did not itself contain a ready-made cure. It contained a clue. Fleming’s attention to that clue, followed by years of work by many people, helped create a treatment that transformed health care. The date is remembered not simply for an accident, but for the moment when an unexpected observation became a question that science could pursue.
